|
Promotional ADHD drug video draws FDA’s rebuke (BizJournals)
WAYNE — A YouTube video featuring a reality television personality touting a Shire attention-deficit disorder drug has gotten the pharmaceutical company in trouble with the Food and Drug Administration.
us.rd.yahoo.com
Sac County Picks Most Expensive Drug-Test Bid (KCRA 3 Sacramento)
Sacramento County officials are defending their choice of the most expensive of four drug testing companies during a time of nationwide belt-tightening.
us.rd.yahoo.com
Sonora Man Faces Drug Charges (KCRA 3 Sacramento)
A Sonora man remains in jail after his arrest on drug charges, police say.
us.rd.yahoo.com
Does treatment for ADHD lead teens to drug, alcohol abuse? (Philly.com)
Do stimulants used to treat adolescents with Attention-Deficit/Hyperactivity Disorder serve as a gateway drug, opening them up to smoking and drug abuse in later years?
us.rd.yahoo.com
ADHD Stimulant Meds Cut Young Girls' Drug Abuse Risk (MedicineNet.com)
Title: ADHD Stimulant Meds Cut Young Girls' Drug Abuse Risk Category: Health News Created: 10/7/2008 2:00:00 AM Last Editorial Review: 10/7/2008
us.rd.yahoo.com
Calendar for October 13 (The Bryan-College Station Eagle)
Mark Your CalendarsAn autumn celebration. Christ's Way Baptist Church, 3885 Copperfield Drive in Bryan, is holding a fall festival from 6 to 8:30 p.m. Oct. 31. ...
us.rd.yahoo.com
Two Men Escape From Prison (CBS 46 News Atlanta)
Two men escape from Hays State Prison in Summerville.
us.rd.yahoo.com
EFFINGHAM EVENTS (Savannah Morning News)
Springfield City Council
us.rd.yahoo.com
ADHD drugs cut young girls' drug abuse risk (New Kerala)
Washington, Oct 7 : Treatment with stimulant drugs appears to significantly decrease the risk that girls with Attention-Deficit Hyperactivity Disorder (ADHD) will begin smoking cigarettes or using alcohol or drugs, a new study has found.
us.rd.yahoo.com
Suven Life Science to present data on SUVN-502 in London (PharmaBiz)
Suven Life Science, a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, is presenting data on its SUVN-502 at the 16th Annual Bio Partnering Europe on October 14, 2008.
us.rd.yahoo.com
|
